Group 6D Poster Presentation by Publishing | May 30, 2020 | COVID-19 Innovation Programme, Poster Presentations | 3 comments 3 Comments Rebecca Glendell on May 30, 2020 at 2:14 pm This is an excellent poster! You have clearly all put a lot of effort in this week! What are some of the ethics regarding giving patients with COVID-19 drugs which haven’t been approved for COVID-19? Reply Tabitha Premraj on May 30, 2020 at 5:44 pm Thank you very much Rebecca! Regarding the ethics of treating COVID-19 patients with drugs which have not been approved, we believed that even though they may help the patient at the moment we are unable to tell the Long Term effect. We have written one bullet point regarding a for and against of using unapproved drugs to treat this virus. Reply Tabitha Premraj on May 30, 2020 at 5:51 pm The long term effects could potentially be harmful, therefore it would go against one of the core principles of medicine, non-maleficence Reply Submit a Comment Cancel reply Your email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Notify me of followup comments via e-mail. You can also subscribe without commenting.